- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/07 - Human cells
Patent holdings for IPC class C12N 15/07
Total number of patents in this class: 80
10-year publication summary
|
8
|
4
|
12
|
8
|
6
|
2
|
2
|
1
|
1
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| President and Fellows of Harvard College | 6104 |
5 |
| The Board of Trustees of the Leland Stanford Junior University | 6678 |
3 |
| Dana-Farber Cancer Institute, Inc. | 2668 |
3 |
| The Regents of the University of California | 20802 |
2 |
| The Johns Hopkins University | 5907 |
2 |
| Case Western Reserve University | 1898 |
2 |
| Cytomatrix Pty Ltd | 6 |
2 |
| KSQ Therapeutics, Inc. | 94 |
2 |
| National University Corporation Tottori University | 206 |
2 |
| Ohio State Innovation Foundation | 2383 |
2 |
| Regents of the University of Minnesota | 2794 |
2 |
| Trans Chromosomics, Inc. | 22 |
2 |
| University of Washington | 2451 |
2 |
| University of Washington through its Center for Commercialization | 504 |
2 |
| Board of Regents, The University of Texas System | 6135 |
1 |
| Life Technologies Corporation | 3457 |
1 |
| The Trustees of the University of Pennsylvania | 4426 |
1 |
| Agency for Science, Technology and Research | 3744 |
1 |
| Alfresa Pharma Corporation | 52 |
1 |
| Amsterdam Molecular Therapeutics (amt) B.V. | 1 |
1 |
| Other owners | 41 |